Invention Grant
- Patent Title: Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces
-
Application No.: US15141036Application Date: 2016-04-28
-
Publication No.: US09987328B2Publication Date: 2018-06-05
- Inventor: Stefan Zeitler , Marc Nolte , Stefan Schulte , Gerhard Dickneite , Ingo Pragst
- Applicant: CSL Behring GmbH
- Applicant Address: DE Marburg
- Assignee: CSL Behring GmbH
- Current Assignee: CSL Behring GmbH
- Current Assignee Address: DE Marburg
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: EP11157557 20110309
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K38/17 ; A61K38/55 ; A61K38/57 ; C07K16/36 ; C07K16/40 ; A61K31/727 ; A61K38/16 ; A61K38/58 ; A61K39/395 ; A61L33/00 ; A61L33/12 ; A61K47/65 ; A61K47/64
Abstract:
An inhibitor of FXII/FXIIa for the prevention of the formation and/or stabilization of thrombi during and/or after a medical procedure performed on a human or animal subject comprising contacting blood of said human or animal subject with artificial surfaces, wherein said inhibitor of FXII/FXIIa is administered before and/or during and/or after said medical procedure.
Public/Granted literature
Information query
